Policy

Dr. Matthias Wienold , our board member and Treasurer, attended the high profile 2nd Global Ministerial Summit on Patient Safety in Bonn in March 2017 and reports back on the launch of the 3rd Global Patients Safety Challenge: Medication Without Harm. IAPO and its members will support this campaign over the coming years.
This month’s policy briefing focuses on access, which is the second “key theme” of the 2017 engagement and empowerment plan . Access and support also feature amongst the five principles of the IAPO Declaration on Patient Centred Healthcare . Every patient must have access to the healthcare services...
Patient information is one of the pillars of the IAPO Declaration of patient-centred healthcare. It represents a primary vehicle for patient advocates to better engage in and contribute to healthcare more effectively. For this to happen, however, it is crucial that patients play an active role in the information process.
The International Conference of Drug Regulatory Authorities (ICDRA) is an annual event hosted for the benefit of the WHO Member States and their national medicines regulatory authorities (NMRAs); many non-State actors attend a pre-ICDRA conference to share their views with NMRAs. The 17th pre-ICDRA...
UK Supreme Court (UKSC) judgment in Montgomery v Lanarkshire Health Board has closed the gap between ‘legal consent’, ‘informed consent’ and the ‘best interest’ of the patients. The full judgment, the point of law decided and the rationale for the decision (ratio decidendi) of this important case...
WHO World Health Assembly (May 2016), WHO Regional Committee Meetings (Sep-Oct 2016) and the UN General Assembly Debate (Sep 2016) had great discussions on SDG 2030, UHC and health workforce strengthening. Kawaldip Sehmi, our CEO, has assembled critical thinking on this matter of some of the '...
Dr. Matthias Wienold (IAPO Treasurer and Board Member) and Stijntje Dijk (Liaison Officer International Federation of Medical Students Associations (IFMSA) ) Stijntje, whom you all met at our Global Patients Congress 2016, and I held a joint workshop at the Association for Medical Education in...
Board member Hussain Jafri reporting from the multi-stakeholder hearing of the UN General Assembly High-Level Summit on migrants and refugees 18-22 July 2016, United Nations, New York The most vulnerable patients in the world From the jungles of Central America, deserts of North Africa to the...
Corruption in the health sector can mean the difference between life and death, and the poorest people around the world are the worst affected.
A group of 18 leading biopharmaceutical companies have come together share ideas, simplify and speed up the research and development of new drugs, and improve patient experience around the globe.

Pages

Subscribe to RSS - Policy